Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study

M. Humbert, P. de Groote, V. Gressin, J. Sibilia, E. Diot, P. Carpentier, L. Mouthon, P. Y. Hatron, P. Jego, Y. Allanore, K. P. Tiev, C. Agard, A. Cosnes, D. Cirstea, J. Constans, D. Farge, J. F. Viallard, J. R. Harle, P. Clerson, E. Hachulla (Clamart, Pa

Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Session: Pulmonary arterial hypertension and other pulmonary vascular diseases
Session type: E-Communication Session
Number: 1417
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Humbert, P. de Groote, V. Gressin, J. Sibilia, E. Diot, P. Carpentier, L. Mouthon, P. Y. Hatron, P. Jego, Y. Allanore, K. P. Tiev, C. Agard, A. Cosnes, D. Cirstea, J. Constans, D. Farge, J. F. Viallard, J. R. Harle, P. Clerson, E. Hachulla (Clamart, Pa. Incidence of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study. Eur Respir J 2008; 32: Suppl. 52, 1417

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival of pulmonary arterial hypertension related to systemic sclerosis: a 3-year nationwide longitudinal study
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008


Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Source: Eur Respir J, 50 (1) 1700217; 10.1183/13993003.00217-2017
Year: 2017



Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort
Source: Eur Respir J, 49 (5) 1602275; 10.1183/13993003.02275-2016
Year: 2017



Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018



Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018
Year: 2019



Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011



The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

Prevalence of pulmonary arterial hypertension in idiopathic pulmonary fibrosis: a multicenter study
Source: Eur Respir J 2007; 30: Suppl. 51, 119s
Year: 2007

Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011


ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Source: Eur Respir J 2012; 39: 945-955
Year: 2012



Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019
Year: 2019



Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Early pulmonary hemodynamical changes in systemic sclerosis. A one-year follow-up
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009


French pulmonary arterial hypertension registry in children: 2-year follow-up data
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009


Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008


Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018



Hemodynamic predictors of survival in scleroderma related pulmonary hypertension: a single center study
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007



Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019
Year: 2020



Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009